apoE4 risk_factor_for Alzheimer's disease
Evidence from:
primary |
all sources
Evidence (3 sources)
Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector.
(2018)
PMID:29632371
cited
apoE4-related AD
confidence: 0.93
Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector.
(2018)
PMID:29632371
cited
apoE4’s detrimental effects in AD pathogenesis
confidence: 0.90
Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector.
(2018)
PMID:29632371
cited
apoE4 ... toxic effects ... in AD pathogenesis
confidence: 0.90